SCHEMBL17178602

SCHEMBL17178602

Cc1cc(F)c(N)[nH]c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.38
▸ GRIN2D O15399 3/20 0.38
▸ GRIN3B O60391 3/20 0.38
▸ GRIN1 Q05586 3/20 0.38
▸ GRIN2A Q12879 3/20 0.38
▸ GRIN2B Q13224 3/20 0.38
▸ GRIN2C Q14957 3/20 0.38
▸ GRIN3A Q8TCU5 3/20 0.38
▸ ATAD2 Q6PL18 2/20 0.35
▸ TYMP P19971 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ DAO P14920 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17178597 0.79 GRIN2D (0.42) BRD4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL15740082 0.74 DPYD (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL17178599 0.74 DPYD (0.37) BRD4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17178592 0.72 GRIN2D (0.43) BRD4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL16631740 0.70 GRIN2D (0.42) BRD4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17178600 0.69 KDM4E (0.40) BRD4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL24550532 0.68 HSD17B10 (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL17121353 0.68 TSHR (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5173194 0.66 — —
SCHEMBL12970080 0.65 BRD4 (0.43) BRD4GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3251674-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BioCryst Pharmaceuticals, Inc. (US) 2017-12-06 — — EP disclosed
US-20170267681-A1 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES MIDCAP FINANCIAL TRUST, AS AGENT 2017-09-21 — — US disclosed
US-20150291596-A1 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BIOCRYST PHARMACEUTICALS, INC. 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291596-A1 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES RNGTT, DUT, RNMT BRD4 1580/4885GRIN2D 3271/4885GRIN3B 2151/4885
US-20170267681-A1 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES RNGTT, DUT, RNMT BRD4 1580/4885GRIN2D 3271/4885GRIN3B 2151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback